1. Home
  2. HZO vs ALLO Comparison

HZO vs ALLO Comparison

Compare HZO & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

N/A

Current Price

$26.41

Market Cap

591.7M

ML Signal

N/A

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

N/A

Current Price

$2.19

Market Cap

539.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HZO
ALLO
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
591.7M
539.4M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
HZO
ALLO
Price
$26.41
$2.19
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$30.00
$8.40
AVG Volume (30 Days)
434.3K
4.3M
Earning Date
04-23-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.09
EPS
N/A
N/A
Revenue
$2,309,288,000.00
N/A
Revenue This Year
$3.02
N/A
Revenue Next Year
$4.04
$140,929.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.85
$0.86
52 Week High
$32.00
$2.80

Technical Indicators

Market Signals
Indicator
HZO
ALLO
Relative Strength Index (RSI) 45.91 48.43
Support Level $24.44 $1.04
Resistance Level $28.13 $2.76
Average True Range (ATR) 1.37 0.21
MACD -0.14 -0.06
Stochastic Oscillator 38.82 19.70

Price Performance

Historical Comparison
HZO
ALLO

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: